The lack of a significant role for DNAM-1 pathway in kidney transplantation is quite surprising, since DNAM-1 and its ligands CD155 and CD112 are important in NK and T cell mediated anti-tumor activity [4, 8, 34] and play a role in graft versus host disease [11, 22]. This evidence concerns the gene PVR and neoplasm.